| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.4M | — | -2.7% |
| Cost of Revenue | $7.5M | — | -13.5% |
| Gross Profit | $10.9M | — | +6.6% |
| R&D Expense | $3.0M | — | +61.3% |
| SG&A Expense | $4.0M | — | -25.5% |
| Operating Income | $713K | — | +465.9% |
| Pre-tax Income | $970K | — | +259.3% |
| Income Tax | $294K | — | +359.4% |
| Net Income | $676K | — | +228.2% |
| EPS (Basic) | $0.03 | — | +200.0% |
| EPS (Diluted) | $0.03 | — | +200.0% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.2M | -2.2% | +387.9% |
| Short-term Investments | $5.5M | +266.7% | -54.1% |
| Accounts Receivable | $12.2M | +25.1% | -5.1% |
| Current Assets | $58.1M | +12.8% | +43.9% |
| Total Assets | $137.8M | +4.5% | -30.0% |
| Current Liabilities | $10.3M |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.2M | — | +432.3% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$4.9M | — | -56.2% |
| Financing Cash Flow | $2K | — | -99.3% |
| Free Cash Flow | $4.2M | — | +411.3% |
| +6.2% |
| Total Liabilities | $10.7M | +50.2% | -12.3% |
| Stockholders' Equity | $127.1M | +1.9% | -31.2% |